Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Jun;59(6):2075–2082. doi: 10.1128/iai.59.6.2075-2082.1991

Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.

A Pantosti 1, A O Tzianabos 1, A B Onderdonk 1, D L Kasper 1
PMCID: PMC257968  PMID: 2037368

Abstract

Immunochemical analysis of the capsular polysaccharide from Bacteroides fragilis NCTC 9343 revealed a novel structure composed of two distinct polysaccharides. Immunoelectrophoresis of an extract of purified surface polysaccharide from fermenter-grown organisms showed a complex precipitin profile with varying anodal mobility. DEAE-Sephacel anion-exchange chromatography of the polysaccharide extract failed to separate the majority of this aggregate. Disaggregation of this complex was accomplished by very mild acid treatment; purification was achieved by DEAE-Sephacel anion-exchange chromatography. Polysaccharide A had a neutral charge at pH 7.3, a net negative charge at pH 8.6, and an average Mr = 110,000; chemical analysis showed it to contain galactose, galactosamine, and an unidentified amino sugar. Polysaccharide B eluted from the anion-exchange column with increased salt concentration; it had a net negative charge and an average Mr = 200,000, and contained fucose, galactose, quinovosamine, galacturonic acid, and glucosamine. Neither of these polysaccharides contained detectable 3-deoxy-D-manno-octolusonic acid, and both were recognized as distinct antigens on the basis of their reactivity with monoclonal antibodies CE3 and F10, which reacted with the complex before acid treatment. These data indicate that the capsule of B. fragilis NCTC 9343 comprises two discrete, surface-exposed polysaccharides with differing physiochemical properties that are distinct from the lipopolysaccharide of this organism. The finding of two surface polysaccharides has not been described for other bacteria pathogenic to humans.

Full text

PDF
2075

Images in this article

2077Image
on p.2077
2078Image
on p.2078
2078Image
on p.2078
2078Image
on p.2078
2079Image
on p.2079
2079Image
on p.2079

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Sherwood J. E., Hollingsworth R. I., Dazzo F. B. Stimulation of clover root hair infection by lectin-binding oligosaccharides from the capsular and extracellular polysaccharides of Rhizobium trifolii. J Bacteriol. 1984 Nov;160(2):517–520. doi: 10.1128/jb.160.2.517-520.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Babb J. L., Cummins C. S. Encapsulation of Bacteroides species. Infect Immun. 1978 Mar;19(3):1088–1091. doi: 10.1128/iai.19.3.1088-1091.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brade H., Galanos C., Lüderitz O. Differential determination of the 3-Deoxy-D-mannooctulosonic acid residues in lipopolysaccharides of Salmonella minnesota rough mutants. Eur J Biochem. 1983 Mar 1;131(1):195–200. doi: 10.1111/j.1432-1033.1983.tb07249.x. [DOI] [PubMed] [Google Scholar]
  4. Brook I., Coolbaugh J. C., Walker R. I. Pathogenicity of piliated and encapsulated Bacteroides fragilis. Eur J Clin Microbiol. 1984 Jun;3(3):207–209. doi: 10.1007/BF02014880. [DOI] [PubMed] [Google Scholar]
  5. Caroff M., Lebbar S., Szabó L. Do endotoxins devoid of 3-deoxy-D-manno-2-octulosonic acid exist? Biochem Biophys Res Commun. 1987 Mar 30;143(3):845–847. doi: 10.1016/0006-291x(87)90326-3. [DOI] [PubMed] [Google Scholar]
  6. Chaby R., Szabó L. 3-Deoxy-2-octulosonic acid 5-phosphate: a component of the endotoxin of Bordetella pertussis. Eur J Biochem. 1975 Nov 1;59(1):277–280. doi: 10.1111/j.1432-1033.1975.tb02452.x. [DOI] [PubMed] [Google Scholar]
  7. GRABAR P., WILLIAMS C. A. Méthode permettant l'étude conjuguée des proprietés électrophorétiques et immunochimiques d'un mélange de protéines; application au sérum sanguin. Biochim Biophys Acta. 1953 Jan;10(1):193–194. doi: 10.1016/0006-3002(53)90233-9. [DOI] [PubMed] [Google Scholar]
  8. Galfrè G., Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981;73(Pt B):3–46. doi: 10.1016/0076-6879(81)73054-4. [DOI] [PubMed] [Google Scholar]
  9. Goldman R. C., White D., Orskov F., Orskov I., Rick P. D., Lewis M. S., Bhattacharjee A. K., Leive L. A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol. 1982 Sep;151(3):1210–1221. doi: 10.1128/jb.151.3.1210-1221.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gotschlich E. C., Fraser B. A., Nishimura O., Robbins J. B., Liu T. Y. Lipid on capsular polysaccharides of gram-negative bacteria. J Biol Chem. 1981 Sep 10;256(17):8915–8921. [PubMed] [Google Scholar]
  11. Kasper D. L., Baker C. J., Galdes B., Katzenellenbogen E., Jennings H. J. Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. J Clin Invest. 1983 Jul;72(1):260–269. doi: 10.1172/JCI110965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kasper D. L., Onderdonk A. B., Reinap B. G., Linberg A. A. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen. J Infect Dis. 1980 Nov;142(5):750–756. doi: 10.1093/infdis/142.5.750. [DOI] [PubMed] [Google Scholar]
  13. Kasper D. L., Seiler M. W. Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis. J Infect Dis. 1975 Oct;132(4):440–450. doi: 10.1093/infdis/132.4.440. [DOI] [PubMed] [Google Scholar]
  14. Kasper D. L. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition. J Infect Dis. 1976 Jan;133(1):79–87. doi: 10.1093/infdis/133.1.79. [DOI] [PubMed] [Google Scholar]
  15. Kasper D. L., Weintraub A., Lindberg A. A., Lönngren J. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J Bacteriol. 1983 Feb;153(2):991–997. doi: 10.1128/jb.153.2.991-997.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kuhn H. M., Neter E., Mayer H. Modification of the lipid moiety of the enterobacterial common antigen by the "Pseudomonas factor". Infect Immun. 1983 May;40(2):696–700. doi: 10.1128/iai.40.2.696-700.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kuo J. S., Doelling V. W., Graveline J. F., McCoy D. W. Evidence for covalent attachment of phospholipid to the capsular polysaccharide of Haemophilus influenzae type b. J Bacteriol. 1985 Aug;163(2):769–773. doi: 10.1128/jb.163.2.769-773.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Lambe D. W., Jr, Mayberry-Carson K. J., Ferguson K. P. Morphological stabilization of the glycocalyces of 23 strains of five Bacteroides species using specific antisera. Can J Microbiol. 1984 Jun;30(6):809–819. doi: 10.1139/m84-124. [DOI] [PubMed] [Google Scholar]
  20. Lindberg A. A., Berthold P., Nord C. E., Weintraub A. Encapsulated strains of Bacteroides fragilis in clinical specimens. Med Microbiol Immunol. 1979 Mar 13;167(1):29–36. doi: 10.1007/BF02123293. [DOI] [PubMed] [Google Scholar]
  21. Lindberg A. A., Weintraub A., Zähringer U., Rietschel E. T. Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis. 1990 Jan-Feb;12 (Suppl 2):S133–S141. doi: 10.1093/clinids/12.supplement_2.s133. [DOI] [PubMed] [Google Scholar]
  22. Michon F., Katzenellenbogen E., Kasper D. L., Jennings H. J. Structure of the complex group-specific polysaccharide of group B Streptococcus. Biochemistry. 1987 Jan 27;26(2):476–486. doi: 10.1021/bi00376a020. [DOI] [PubMed] [Google Scholar]
  23. Mäkelä P. H., Mayer H. Enterobacterial common antigen. Bacteriol Rev. 1976 Sep;40(3):591–632. doi: 10.1128/br.40.3.591-632.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. OUCHTERLONY O. Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958;5:1–78. [PubMed] [Google Scholar]
  25. Omar A. S., Weckesser J., Mayer H. Different polysaccharides in the external layers (capsule and slime) of the cell envelope of Rhodopseudomonas capsulata Sp11. Arch Microbiol. 1983 Dec;136(4):291–296. doi: 10.1007/BF00425219. [DOI] [PubMed] [Google Scholar]
  26. Onderdonk A. B., Kasper D. L., Cisneros R. L., Bartlett J. G. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977 Jul;136(1):82–89. doi: 10.1093/infdis/136.1.82. [DOI] [PubMed] [Google Scholar]
  27. Onderdonk A. B., Markham R. B., Zaleznik D. F., Cisneros R. L., Kasper D. L. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest. 1982 Jan;69(1):9–16. doi: 10.1172/JCI110445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Patrick S., Reid J. H., Coffey A. Capsulation of in vitro and in vivo grown Bacteroides species. J Gen Microbiol. 1986 Apr;132(4):1099–1109. doi: 10.1099/00221287-132-4-1099. [DOI] [PubMed] [Google Scholar]
  29. Patrick S., Reid J. H., Larkin M. J. The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro. J Med Microbiol. 1984 Jun;17(3):237–246. doi: 10.1099/00222615-17-3-237. [DOI] [PubMed] [Google Scholar]
  30. Patrick S., Reid J. H. Separation of capsulate and non-capsulate Bacteroides fragilis on a discontinuous density gradient. J Med Microbiol. 1983 May;16(2):239–241. doi: 10.1099/00222615-16-2-239. [DOI] [PubMed] [Google Scholar]
  31. Polk B. F., Kasper D. L. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med. 1977 May;86(5):569–571. doi: 10.7326/0003-4819-86-5-569. [DOI] [PubMed] [Google Scholar]
  32. Poxton I. R., Brown R. Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen. J Gen Microbiol. 1986 Sep;132(9):2475–2481. doi: 10.1099/00221287-132-9-2475. [DOI] [PubMed] [Google Scholar]
  33. Reid J. H., Patrick S. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis. J Med Microbiol. 1984 Jun;17(3):247–257. doi: 10.1099/00222615-17-3-247. [DOI] [PubMed] [Google Scholar]
  34. Reid J. H., Patrick S., Tabaqchali S. Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody. J Gen Microbiol. 1987 Jan;133(1):171–179. doi: 10.1099/00221287-133-1-171. [DOI] [PubMed] [Google Scholar]
  35. Shapiro M. E., Onderdonk A. B., Kasper D. L., Finberg R. W. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med. 1982 Apr 1;155(4):1188–1197. doi: 10.1084/jem.155.4.1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sturm S., Fortnagel P., Timmis K. N. Immunoblotting procedure for the analysis of electrophoretically-fractionated bacterial lipopolysaccharide. Arch Microbiol. 1984 Dec;140(2-3):198–201. doi: 10.1007/BF00454926. [DOI] [PubMed] [Google Scholar]
  37. Taylor R. L., Conrad H. E. Stoichiometric depolymerization of polyuronides and glycosaminoglycuronans to monosaccharides following reduction of their carbodiimide-activated carboxyl groups. Biochemistry. 1972 Apr 11;11(8):1383–1388. doi: 10.1021/bi00758a009. [DOI] [PubMed] [Google Scholar]
  38. Weintraub A., Lindberg A. A., Kasper D. L. Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence. J Infect Dis. 1983 Apr;147(4):780–780. doi: 10.1093/infdis/147.4.780. [DOI] [PubMed] [Google Scholar]
  39. Weintraub A., Zähringer U., Lindberg A. A. Structural studies of the polysaccharide part of the cell wall lipopolysaccharide from Bacteroides fragilis NCTC 9343. Eur J Biochem. 1985 Sep 16;151(3):657–661. doi: 10.1111/j.1432-1033.1985.tb09154.x. [DOI] [PubMed] [Google Scholar]
  40. Wollenweber H. W., Rietschel E. T., Hofstad T., Weintraub A., Lindberg A. A. Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol. 1980 Dec;144(3):898–903. doi: 10.1128/jb.144.3.898-903.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zaleznik D. F., Zhang Z. L., Onderdonk A. B., Kasper D. L. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide. J Infect Dis. 1986 Jul;154(1):40–46. doi: 10.1093/infdis/154.1.40. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES